Enclosed herewith audited financial results (standalone & consolidated) for the quarter and financial year ended March 31, 2026.
JNKINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.8 pts more than Nifty Microcap 250 and 8.3 pts more than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
JNK India reported strong full-year results with standalone revenue growing 59.7% to Rs 7,556 million from Rs 4,732 million in FY25. PAT surged 115.2% to Rs 648.7 million versus Rs 301.4 million in the prior year. Basic EPS jumped to Rs 15.9 from Rs 5.44 annualised. The Board recommended a final dividend of Rs 0.30 per share (15% on face value of Rs 2). The company completed an IPO in April 2024 and has invested in a new subsidiary, JNK Chemdist Technologies Private Limited, which became operational in Q3 FY26. Auditors issued unmodified opinions on both standalone and consolidated results with no qualifications.
The company delivered exceptional growth with PAT more than doubling year-on-year. The stock should be viewed positively given strong revenue momentum, improved profitability, and consistent cash generation. The new Process Equipment segment adds diversification.